The NIH is the world’s largest public funder of biomedical research. VUSM, which received $586 million in direct and indirect NIH grant support in FY24, has been among the top 10 recipients of NIH funding among U.S. medical schools for nine of the past 15 years.

The award is the highest honor bestowed by the U.S. government on scientists and engineers in the early stages of their research careers.

This project will be the first to apply drug conjugates in the field of obstetrics.

Each fellow holds the title for two years, receives $40,000 per year to support their work, and meets with their cohort to exchange ideas, build a broader intellectual community and engage in academic leadership development.

The “Molecular Muse” art exhibit on display in Light Hall is a sampling of pieces from the Vanderbilt Institute for Infection, Immunology and Inflammation Artist-in-Residence (VI4-AiR) program, which brings together scientists and artists to create and promote art as a visual science communication tool.

Richard Caprioli, C. David Weaver, Susan Eagle, and Franz Baudenbacher as Master Innovators at Vanderbilt.

Vanderbilt researchers have uncovered a potential new way to help curb the rapidly rising worldwide prevalence of metabolic disorders, including obesity and diabetes.